课题基金 / 基金详情

Investigation o the factors involved in proliferation and angiogenesis of malignant glioma : study on heparin-binding EGF-like growth factor (HB-EGF)

Investigation o the factors involved in proliferation and angiogenesis of malignant glioma : study on heparin-binding EGF-like growth factor (HB-EGF)
恶性胶质瘤增殖和血管生成相关因素的研究:肝素结合EGF样生长因子(HB-EGF)的研究
批准号:
08671567
负责人:
TANIGUCHI Makoto
金额:
$1.6万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

TANIGUCHI Makoto的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The objective of the present study is to investigate the role of heparin-binding EGF-like growth factor(HB-EGF), which is highly expressed in glioma cells, in progression of malignant glioma, focusing on its effect on the angiogenesis and cellular infiltration.(A)Involvement of HB-EGF in proliferation of glioma cellsApplying recombinant HB-EGF(rHB-EGF)to glioma cells facilitated the proliferation and DNA synthesis of those cells. Applying specific antibody against HB-EGF to glioma cells inhibited proliferation down to 70% of the control. These results suggested that HB-EGF is strongly involved in proliferation of glioma as an autocrine proliferative factor.(B)Involvement of HB-EGF in angiogenesis of gliomaApplying rHB-EGF to cultured glioma cells induced expression of vascular endothelial growth factor(VEGF)mRNA,which was evaluated by Northern hybridization method. The effect was initiated at 3 hours after the application of rHB-EGF and was dose-dependent. Secretion of VEGF protein, which was evaluated by Western blotting anslysis, was also increased by application of rHB-EGF.The study demonstrated that HB-EGF is not only essential for proliferation of glioma cells but also contributes to angiogenesis of glioma via upregulation of VEGF.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Kazuhiko, Mishima.et al.: "Increased expression of midkine during the progression of human astrocy-tomas" Neuroscience Letters. 233. 29-32 (1997)
Kazuhiko, Mishima.et al.:“人类星形细胞瘤进展过程中中期因子的表达增加”神经科学快报。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kazuhiko Mishima, Akio Asai, Kenji Kadomatsu, Yasushi Ino, Kazuhiro Nomura, Yoshitaka Narita, Takashi Muramatsu, Takaaki Kirino: "Increase expression of midline during the pregression of human astorcytomas" Neuroscience Letters. 233. 29-32 (1997)
Kazuhiko Mishima、Akio Asai、Kenji Kadomatsu、Yasushi Ino、Kazuhiro Nomura、Yoshitaka Narita、Takashi Muramatsu、Takaaki Kirino:“在人类星形细胞瘤进展过程中增加中线表达”神经科学快报。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
三島一彦他: "グリオーマにおけるヘパリン結合性EGF様増殖因子(HB-EGF)の役割(血管新生との関与)" 脳と免疫研究(Neuroimmunological Research). 9. 242-245 (1996)
Kazuhiko Mishima 等人:“肝素结合 EGF 样生长因子 (HB-EGF) 在神经胶质瘤中的作用(参与血管生成)”神经免疫学研究。 9. 242-245 (1996)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
三島 一彦 他: "グリオーマにおけるヘパリン結合性EGF様増殖因子(HB-EGF)の役割(血管新生との関与)" 脳と免疫研究(Neuroimmunological Resear-ch). 9. 242-245 (1996)
Kazuhiko Mishima 等人:“肝素结合 EGF 样生长因子 (HB-EGF) 在神经胶质瘤中的作用(参与血管生成)”《神经免疫学研究》第 9 章 242-245 (1996)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
8
    Elucidation of the involvement of sphingomyelin synthase in acute myeloid leukemia progression
    • 批准号:
      17K18205
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.75万
    • 财政年份:
      2017
    • 负责人:
      TANIGUCHI Makoto
    • 依托单位:
    Role of Sphingomyelin/lipid raft on Japanese encephalitis virus infection
    • 批准号:
      25870853
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.75万
    • 财政年份:
      2013
    • 负责人:
      TANIGUCHI Makoto
    • 依托单位:
    Impacts of subsurface warming on cherry blossom blooming
    • 批准号:
      24650607
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2012
    • 负责人:
      TANIGUCHI Makoto
    • 依托单位:
    Global analysis of two-component signal transduction systems in Streptococcus mutans
    • 批准号:
      23890207
    • 项目类别:
      Grant-in-Aid for Research Activity Start-up
    • 资助金额:
      $2.08万
    • 财政年份:
      2011
    • 负责人:
      TANIGUCHI Makoto
    • 依托单位:
    海外基金